Urine Cytology Market Research Report - Global forecast till 2027

Urine Cytology Market Information: By Product (Urine Cytology Instrument, Urine Cytology Kit), By Indication (Urinary Infection, Inflammatory Disease, Cancer), By End User (Hospitals & Clinics, Diagnostic Centers, Home Care) - Global Forecast till 2027

ID: MRFR/MED/3680-HCR | | Region: Global | 110 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data

Intended Audience



  • Medical Device Manufacturers

  • Medical Device Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology
Urine Cytology Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Market Synopsis of the Global Urine Cytology Market


Cytology is an emerging field in healthcare that plays an important role in the diagnosis of various diseases such as cancer, and chronic diseases. It involves the examination of cells of the body under a microscope. In urine cytology, urine specimen is collected from the patient to determine the functioning of the cells. The healthcare provider may recommend urine cytology examination if the patient has symptoms such as unexplained blood in the urine, burning and pain during urination. It is commonly used for the diagnosis of infection, inflammatory disease of the urinary tract, cancer of kidney, bladder, ureter, urethra, and others.


Rising prevalence of chronic diseases such as urinary tract infection, and cancer, increasing demand for urine tests, and the presence of key players in the market are important drivers that accelerate the growth of the market. Increasing demand for testing kits for home care is another key driver for the market growth. Additionally, increasing focus on diagnostic services in both the developing and developed regions across the globe also influences the growth of the market. Furthermore, replacement of manual instruments by automated ones in the hospitals and diagnostic centers also fuels the progress of the market. Although competition among key players in the market may act as a barrier for new entrants.


The global urine cytology market is expected to grow at a CAGR of 5.2% during the forecast period. 


FIGURE 1: Global Urine Cytology Market by Region, 2016 (%)



Global Urine Cytology Market


Source: World Health Organization, Centers for Disease Control and Prevention (CDC), European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation 


Segments 


The global urine cytology market is segmented on the basis of product, indication, and end user.


On the basis of product, market is segmented into urine cytology instrument, urine cytology kit, and others. Product is further segmented into automated, and manual instrument.


On the basis of indication, the market is segmented into urinary infection, inflammatory disease, cancer, and others. Cancer is further segmented into kidney, bladder, ureter, and urethra.


On the basis of end user, the market is segmented into hospitals & clinics, diagnostic centers, home care, and others.


Regional Analysis of the Global Urine Cytology Market                       


America acquires a leading position in the market for urine cytology, owing to the rising prevalence of various urinary tract infection, inflammatory disease, and cancer. Additionally, presence of key players manufacturing urine urology kits, and devices. The major players are engaged in various strategic approaches such as merger, acquisition, partnership, collaborations, and new product, and others to strengthen their position in the market. ThermoFischer Scientific, BD, and Sigma- Aldrich are 3 major players in the U.S. market.


 Europe is the second largest market for urine cytology owing to the availability of funds for research and development activities. Also, rising prevalence of cancer, increasing demand for diagnostic services and rising awareness about urine cytology for the diagnosis of diseases for urinary tract the market growth.


The market in Asia Pacific is expected to grow at the fastest pace and is driven by the rising prevalence of urinary tract infection which would act as a major risk factor for the growth of the market. Furthermore, rising awareness about the use of urine cytology for the diagnosis of urinary tract infection also influences the growth of the market. Additionally, changing lifestyle and rising geriatric population also drive the growth of the market. Furthermore, rising expenditure on healthcare by the developing countries in Asia Pacific also fuels the growth of the market.


The Middle East & Africa also show a steady rise in the market owing to high prevalence of chronic diseases such as infection, and cancer and improving healthcare infrastructure. The United Arab Emirates, and Saudi Arabia are the largest contributors to the growth of the market owing to the availability of specialty healthcare resources and demand for diagnostics devices, and test kits. Increasing demand for new treatment options for chronic diseases also influences the market growth in the Middle East & African countries. In Africa, the market shows positive growth owing to increasing prevalence of infectious diseases and demand for healthcare services in the developing and under developing countries.


Key Players in the Global Urine Cytology Market         


Some of the key players in this market are ThermoFischer Scientific (U.S.), BD (U.S.), Sigma- Aldrich (U.S.), Severn Biotech Limited (U.K), Bio-Techne (U.S), Laboratory Corporation of America Holdings (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), and others.



Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Urine Cytology Market, By Product

6.1 Introduction

6.2 Urine Cytology Instrument

6.2.1 Market Estimates & Forecast, 2020 – 2027

6.3 Urine Cytology Kit

6.3.1 Market Estimates & Forecast, 2020 – 2027

6.4 Others

6.4.1 Market Estimates & Forecast, 2020 – 2027

Chapter 7. Global Urine Cytology Market, By Indication

7.1 Introduction

7.2 Urinary Infection

7.2.1 Market Estimates & Forecast, 2020 – 2027

7.3 Inflammatory Disease

7.3.1 Market Estimates & Forecast, 2020 – 2027

7.4 Cancer

7.4.1 Market Estimates & Forecast, 2020 – 2027

7.5 Others

7.5.1 Market Estimates & Forecast, 2020 – 2027

Chapter 8. Global Urine Cytology Market, By End User

8.1 Introduction

8.2 Hospital & Clinics

8.2.1 Market Estimates & Forecast, 2020 – 2027

8.3 Diagnostic Centers

8.3.2 Market Estimates & Forecast, 2020 – 2027

8.4 Home Care

8.4.1 Market Estimates & Forecast, 2020 – 2027

8.5 Others

8.5.2 Market Estimates & Forecast, 2020 – 2027

Chapter 9. Global Urine Cytology Market, By Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 U.K

9.3.1.6 Rest Of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic Of Korea

9.4.6 Rest Of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest Of The Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 ThermoFischer Scientific

11.1.1 Company Overview

11.1.2 Products Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Merck & Co.

11.2.1 Company Overview

11.2.2 Products Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Sigma- Aldrich

11.3.1 Company Overview

11.3.2 Products Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Severn Biotech Limited

11.4.1 Company Overview

11.4.2 Products/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Bio-Techne

11.5.1 Company Overview

11.5.2 Products Overview

11.5.3 Financial Overview

11.5.4 Key Developments

11.6 Laboratory Corporation Of America Holdings

11.6.1 Company Overview

11.6.2 Products Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 F. HOFFMANN-LA ROCHE LTD

11.7.1 Overview

11.7.2 Products Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs Of The Market

12.2 Key Companies To Watch

12.3 Prediction Of Urine Cytology Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Urine Cytology Industry Synopsis, 2020 – 2027

Table 2 Urine Cytology Market Estimates And Forecast, 2020 – 2027, (USD Million)

Table 3 Urine Cytology Market By Region, 2020 – 2027, (USD Million)

Table 4 Urine Cytology Market By Product, 2020 – 2027, (USD Million)

Table 5 Urine Cytology Market By Indication, 2020 – 2027, (USD Million)

Table 6 Urine Cytology Market By End Users, 2020 – 2027, (USD Million)

Table 7 North America Urine Cytology Market By Product, 2020 – 2027, (USD Million)

Table 8 North America Urine Cytology Market By Indication, 2020 – 2027, (USD Million)

Table 9 North America Urine Cytology Market By End Users, 2020 – 2027, (USD Million)

Table 10 US Urine Cytology Market By Product, 2020 – 2027, (USD Million)

Table 11 US Urine Cytology Market By Indication, 2020 – 2027, (USD Million)

Table 12 US Urine Cytology Market By End Users, 2020 – 2027, (USD Million)

Table 13 Canada Urine Cytology Market By Product, 2020 – 2027, (USD Million)

Table 14 Canada Urine Cytology Market By Indication, 2020 – 2027, (USD Million)

Table 15 Canada Urine Cytology Market By End Users, 2020 – 2027, (USD Million)

Table 16 South America Urine Cytology Market By Product, 2020 – 2027, (USD Million)

Table 17 South America Urine Cytology Market By Indication, 2020 – 2027, (USD Million)

Table 18 South America Urine Cytology Market By End Users, 2020 – 2027, (USD Million)

Table 19 Europe Urine Cytology Market By Product, 2020 – 2027, (USD Million)

Table 20 Europe Urine Cytology Market By Indication, 2020 – 2027, (USD Million)

Table 21 Europe Urine Cytology Market By End Users, 2020 – 2027, (USD Million)

Table 22 Western Europe Urine Cytology Market By Product, 2020 – 2027, (USD Million)

Table 23 Western Europe Urine Cytology Market By Indication, 2020 – 2027, (USD Million)

Table 24 Western Europe Urine Cytology Market By End Users, 2020 – 2027, (USD Million)

Table 25 Eastern Europe Urine Cytology Market By Product, 2020 – 2027, (USD Million)

Table 26 Eastern Europe Urine Cytology Market By Indication, 2020 – 2027, (USD Million)

Table 27 Eastern Europe Urine Cytology Market By End Users, 2020 – 2027, (USD Million)

Table 28 Asia Pacific Urine Cytology Market By Product, 2020 – 2027, (USD Million)

Table 29 Asia Pacific Urine Cytology Market By Indication, 2020 – 2027, (USD Million)

Table 30 Asia Pacific Urine Cytology Market By End Users, 2020 – 2027, (USD Million)

Table 31 Middle East & Africa Urine Cytology Market By Product, 2020 – 2027, (USD Million)

Table 32 Middle East & Africa Urine Cytology Market By Indication, 2020 – 2027, (USD Million)

Table 33 Middle East & Africa Urine Cytology Market By End Users, 2020 – 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Urine Cytology Market

Figure 3 Segmentation Market Dynamics For Urine Cytology Market

Figure 4 Global Urine Cytology Market Share, By Product 2020

Figure 5 Global Urine Cytology Market Share, By Indication 2020

Figure 6 Global Urine Cytology Market Share, By End Users, 2020

Figure 7 Global Urine Cytology Market Share, By Region, 2020

Figure 8 North America Urine Cytology Market Share, By Country, 2020

Figure 9 Europe Urine Cytology Market Share, By Country, 2020

Figure 10 Asia Pacific Urine Cytology Market Share, By Country, 2020

Figure 11 Middle East & Africa Urine Cytology Market Share, By Country, 2020

Figure 12 Global Urine Cytology Market: Company Share Analysis, 2020 (%)

Figure 13 ThermoFischer Scientific: Key Financials

Figure 14 ThermoFischer Scientific Segmental Revenue

Figure 15 ThermoFischer Scientific: Geographical Revenue

Figure 16 BD: Key Financials

Figure 17 BD: Segmental Revenue

Figure 18 BD: Geographical Revenue

Figure 19 Sigma- Aldrich: Key Financials

Figure 20 Sigma- Aldrich: Segmental Revenue

Figure 21 Sigma- Aldrich: Geographical Revenue

Figure 22 Severn Biotech Limited: Key Financials

Figure 23 Severn Biotech Limited: Segmental Revenue

Figure 24 Severn Biotech Limited: Geographical Revenue

Figure 25 Bio-Techne: Key Financials

Figure 26 Bio-Techne: Segmental Revenue

Figure 27 Bio-Techne Geographical Revenue

Figure 28 Laboratory Corporation Of America Holdings: Key Financials

Figure 29 Laboratory Corporation Of America Holdings: Segmental Revenue

Figure 30 Laboratory Corporation Of America Holdings: Geographical Revenue

Figure 31 F. HOFFMANN-LA ROCHE LTD: Key Financials

Figure 32 F. HOFFMANN-LA ROCHE LTD: Segmental Revenue

Figure 33 F. HOFFMANN-LA ROCHE LTD: Geographical Revenue